Neuroimaging, beta amyloid and tau have been used for AD subtyping [9–13], however, subtypes identified based on image analysis and beta amyloid offer limited mechanistic understanding into AD pathophysiology. The gene discussed is MAPT; the disease is Alzheimer disease.